RAGE contributes to persistent sepsis-induced muscle and mitochondrial alterations
A majority of patients surviving sepsis develop muscle weakness. However, the underlying cellular and molecular pathways remain largely unexplored. To determine whether sepsis leads to long-term persistent muscular consequences and to identify the underlying mechanisms, we used a murine model of reanimated sepsis induced by intraperitoneal injection of a heterologous stool slurry. Muscles were analyzed 3 months later. The oxidative muscle exhibited reduced fatigue resistance and decreased mitochondrial respiration, without a corresponding reduction in mitochondrial OXPHOS proteins. Glycolytic and mixed muscle fibres were atrophied. Markers of oxidative and mitochondrial stress, as well as genes involved in mitochondrial fission, remained present 3 months after sepsis. Low-grade, but significant, muscular inflammation was also measured. Specifically, both the NLRP3 inflammasome and the receptor of Advanced Glycation End-products (RAGE) axis were upregulated. Interestingly, long-term sepsis-induced muscular consequences were not observed in RAGE knockout mice. Overall, we describe for the first time in mice that sepsis causes long-lasting muscle dysfunction after recovery, including mitochondrial alterations and low-grade inflammation, and that RAGE may represent a promising target to mitigate long-term muscle alterations induced by sepsis.
Authors
- Gaëlle Grolaux (ORCID: https://orcid.org/0000-0002-7402-6786)
- Cécile Yelnik (ORCID: https://orcid.org/0000-0003-4260-5035)
- Marie Frimat (ORCID: https://orcid.org/0000-0002-7461-8298)
- Raphaël Favory (ORCID: https://orcid.org/0000-0001-7772-2608)
- Claire Bourel
- Sarah Ducastel (ORCID: https://orcid.org/0000-0002-6894-6260)
- Éric Boulanger (ORCID: https://orcid.org/0000-0002-5204-2849)
- Raphaël Romien
- Sébastien Préau (ORCID: https://orcid.org/0000-0002-8638-7183)
- Benoît Brassart
- Alexandre Pierre (ORCID: https://orcid.org/0000-0001-5343-4599)
- Steve Lancel (ORCID: https://orcid.org/0000-0002-3292-5433)
- Jérémy Lemaire (ORCID: https://orcid.org/0000-0002-3777-0506)
- Michael Howsam (ORCID: https://orcid.org/0000-0002-6344-8908)
- Arthur Dubech
Institutions
- Inserm (FR)
- Université de Lille (FR)
- Institut Pasteur de Lille (FR)
- Centre Hospitalier Universitaire de Lille (FR)
- Hôpital Albert Calmette (FR)
- Hôpital Roger Salengro (FR)
- Hôpital Claude Huriez (FR)
Publication Details
- Journal
- Scientific Reports
- Published
- 2025-11-28
- DOI
- https://doi.org/10.1038/s41598-025-28645-8
- Primary Topic
- Advanced Glycation End Products research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Agence Nationale de la Recherche